Table 2 Univariate analysis of risk factors associated with hospital mortality
Variables | Survival patients n = 40 (40%) | Dead patients n = 60 (60%) | p value |
|---|---|---|---|
Age in years, median [IQR] | 63 [52.0–71.0] | 65.5 [57.0–73.0] | p = 0.250 |
Males, n (%) | 29 (72.5) | 39 (65) | p = 0.560 |
Days since diagnosis, median [IQR] | 4 [0–20.5] | 7.5 [0–20.5] | p = 0.460 |
Histological type, n (%) |  |  | p = 0.790 |
 SCLC | 12 (30) | 18 (30) |  |
 NSCLC | 28 (70) | 42 (70) |  |
Metastatic disease, n (%) | 23 (57.5) | 47 (78) | p = 0.040 |
Prior chemotherapy, n (%) | 7 (17.5) | 13 (22) | p = 0.170 |
Prior radiotherapy, n (%) | 3 (7.5) | 7 (12) | p = 0.250 |
ECOG-PS, n (%) |  |  | p = 0.920 |
 Low (0–1) | 31 (78) | 44 (73) |  |
 High | 9 (22.5) | 15 (25) |  |
SOFA score, points, median [IQR] | 5 [3.5–9.5] | 8 [6.0–14.5] | p = 0.010 |
SAPS II, points, median [IQR] | 42.5 [36.5–55.5] | 56.5 [46.5–71.0] | p = 0.002 |
Admission reason, n (%) |  |  | p = 0.330 |
 Sepsis | 12 (30) | 28 (47) |  |
 Respiratory (excluding septic reasons) | 21 (52.5) | 25 (42) |  |
 Cardiovascular disease | 2 (5) | 2 (3) |  |
 Neurologic | 2 (5) | 2 (3) |  |
 Post-CPA | 0 | 2 (3) |  |
 Other | 3 (7.5) | 1 (2) |  |